Guilin Wang

538 total citations
13 papers, 345 citations indexed

About

Guilin Wang is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Guilin Wang has authored 13 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Guilin Wang's work include Breast Cancer Treatment Studies (3 papers), Stress Responses and Cortisol (2 papers) and Cancer and Skin Lesions (2 papers). Guilin Wang is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Stress Responses and Cortisol (2 papers) and Cancer and Skin Lesions (2 papers). Guilin Wang collaborates with scholars based in China and United States. Guilin Wang's co-authors include Weiping Gao, Jin Hu, Xinyu Liu, Zegang Ma, Qimin Wang, Lin Cui, Ruijuan Zhang, Rongyu Li, Xian Qi and Qiang Zhang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Biomaterials.

In The Last Decade

Guilin Wang

13 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guilin Wang China 8 166 77 57 44 38 13 345
Julia Ivanova Russia 10 171 1.0× 53 0.7× 37 0.6× 50 1.1× 20 0.5× 20 418
Natalia Sevillano United States 14 293 1.8× 26 0.3× 36 0.6× 25 0.6× 66 1.7× 19 546
Mamta D. Naidu United States 10 195 1.2× 29 0.4× 50 0.9× 97 2.2× 39 1.0× 14 466
Toshihiko Tashima Japan 15 253 1.5× 95 1.2× 26 0.5× 46 1.0× 55 1.4× 26 546
Hisae Niki Japan 10 172 1.0× 90 1.2× 24 0.4× 50 1.1× 30 0.8× 12 324
Eszter Lajkó Hungary 12 205 1.2× 28 0.4× 24 0.4× 24 0.5× 25 0.7× 42 368
En‐Chi Liao Taiwan 12 159 1.0× 29 0.4× 37 0.6× 115 2.6× 38 1.0× 24 383
Emine Şalva Türkiye 13 304 1.8× 101 1.3× 115 2.0× 66 1.5× 9 0.2× 44 501

Countries citing papers authored by Guilin Wang

Since Specialization
Citations

This map shows the geographic impact of Guilin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilin Wang more than expected).

Fields of papers citing papers by Guilin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilin Wang. The network helps show where Guilin Wang may publish in the future.

Co-authorship network of co-authors of Guilin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guilin Wang. A scholar is included among the top collaborators of Guilin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilin Wang. Guilin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Xiang, Lei, Qingzhou Li, Guilin Wang, et al.. (2025). Oxyresveratrol as a novel ferroptosis inducer exhibits anticancer activity against breast cancer via the EGFR/PI3K/AKT/GPX4 signalling axis. Frontiers in Pharmacology. 15. 1527286–1527286. 5 indexed citations
3.
Wang, Guilin, et al.. (2023). Encapsulated Papillary Carcinoma of the Breast. Radiology. 308(3). e231038–e231038. 2 indexed citations
4.
Wang, Guilin, et al.. (2022). Mucoepidermoid Carcinoma of the Breast. Radiology. 305(1). 32–32. 4 indexed citations
5.
Li, Yiying, Junting Zhang, Yujie Chen, et al.. (2021). lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia. Molecular Therapy. 29(4). 1411–1424. 29 indexed citations
6.
Deng, Heng, Xiaofang Li, Jiamin Li, et al.. (2019). The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs. Cell Death and Disease. 10(7). 494–494. 5 indexed citations
7.
Wang, Guilin, Panagiotis Tsikouras, Mingquan Huang, et al.. (2019). Radioactive seed localization and wire guided localization in breast cancer: A systematic review and meta-analysis.. PubMed. 24(1). 48–60. 16 indexed citations
8.
Hu, Jin, et al.. (2016). Site-specific in situ growth of an interferon-polymer conjugate that outperforms PEGASYS in cancer therapy. Biomaterials. 96. 84–92. 44 indexed citations
9.
Wang, Qimin, Guilin Wang, & Zegang Ma. (2016). Protective effects of myricetin on chronic stress-induced cognitive deficits. Neuroreport. 27(9). 652–658. 19 indexed citations
10.
Ma, Zegang, Guilin Wang, Lin Cui, & Qimin Wang. (2015). Myricetin Attenuates Depressant-Like Behavior in Mice Subjected to Repeated Restraint Stress. International Journal of Molecular Sciences. 16(12). 28377–28385. 50 indexed citations
11.
Hu, Jin, Guilin Wang, Xinyu Liu, & Weiping Gao. (2015). Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin‐Like Polypeptide Fusion of Interferon Alpha. Advanced Materials. 27(45). 7320–7324. 74 indexed citations
12.
Lü, Wan-Liang, Xian Qi, Qiang Zhang, et al.. (2004). A Pegylated Liposomal Platform: Pharmacokinetics, Pharmacodynamics, and Toxicity in Mice Using Doxorubicin as a Model Drug. Journal of Pharmacological Sciences. 95(3). 381–389. 57 indexed citations
13.
Hwang, Cheol Kyu, Xiuli Wu, Guilin Wang, Chun Sung Kim, & Horace H. Loh. (2003). Mouse μ Opioid Receptor Distal Promoter Transcriptional Regulation by SOX Proteins. Journal of Biological Chemistry. 278(6). 3742–3750. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Ivanova Breakdown of academic impact, for papers by Natalia Sevillano Breakdown of academic impact, for papers by Mamta D. Naidu Breakdown of academic impact, for papers by Toshihiko Tashima Breakdown of academic impact, for papers by Hisae Niki Breakdown of academic impact, for papers by Eszter Lajkó Breakdown of academic impact, for papers by En‐Chi Liao Breakdown of academic impact, for papers by Emine Şalva
Rankless by CCL
2026